Trial Details

Not Recruiting
Basic Information
Clinical ID c2901
Identifier EUCTR2016-003797-40-BE
Trial Title A Phase 2a, Proof of Concept, Open-label Study Evaluating the Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients with active Skin Extra-intestinal Manifestations
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Active Skin Extra-Intestinal Manifestations in Inflammatory Bowel Disease.;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Product Name: APD334 Pharmaceutical Form: Tablet INN or Proposed INN: Not yet available CAS Number: 1206123 97 8 Current Sponsor code: APD334 Other descriptive name: APD334 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 2-
Participant Information
Sponsor Arena Pharmaceuticals, Inc.
City -
Country/Region United States;Belgium;Germany
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE2
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -